Visionary Holdings Secures US$20M for Qingdao Anti-Aging Research and Clinic Chain
Visionary Holdings agreed a proposed US$20 million investment with Qingdao Xihai Rongke to establish a China Anti-Aging Research Center and health management chain in Shandong. Funding is split into three milestone-based payments of 30%, 40% and 30%, with a contingent US$10 million second phase and profitability targeted within one year.
1. Investment Cooperation Agreement
Visionary Holdings entered into an agreement with Qingdao Xihai Rongke Enterprise Operation Management to form a project company that will operate the China Anti-Aging Research Center and a health management center chain in the Qingdao West Coast New Area.
2. Milestone-Based Funding Structure
Under the cooperation, the investor will contribute at least US$20 million in two phases: three milestone-based payments of 30% on project company establishment, 40% upon research center renovation completion, and 30% after the flagship center’s first operating data, plus a contingent US$10 million second phase.
3. Local Support and Infrastructure
The agreement provides for coordination of local resources, preferential office and R&D space, talent housing support, and joint development of a Sino-U.S. life sciences incubator to attract upstream and downstream participants in the Qingdao West Coast New Area.
4. Operational Targets and Timelines
The project aims to achieve profitability for the first anti-aging center within one year of launch and to secure a leading market position in China’s anti-aging sector within two years of investment completion.